310 related articles for article (PubMed ID: 25124080)
1. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro.
Gannon NP; Vaughan RA; Garcia-Smith R; Bisoffi M; Trujillo KA
Int J Cancer; 2015 Feb; 136(4):E197-202. PubMed ID: 25124080
[TBL] [Abstract][Full Text] [Related]
2. Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism.
Vaughan RA; Gannon NP; Mermier CM; Conn CA
J Physiol Biochem; 2015 Dec; 71(4):679-89. PubMed ID: 26399516
[TBL] [Abstract][Full Text] [Related]
3. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
4. Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes.
Kurdiova T; Balaz M; Mayer A; Maderova D; Belan V; Wolfrum C; Ukropec J; Ukropcova B
Peptides; 2014 Jun; 56():1-7. PubMed ID: 24642356
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines.
Moon HS; Mantzoros CS
Metabolism; 2014 Feb; 63(2):188-93. PubMed ID: 24268368
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
8. Browning of white fat: does irisin play a role in humans?
Elsen M; Raschke S; Eckel J
J Endocrinol; 2014 Jul; 222(1):R25-38. PubMed ID: 24781257
[TBL] [Abstract][Full Text] [Related]
9. The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
Hanušová V; Boušová I; Pakostová A; Skálová L
Xenobiotica; 2012 Jun; 42(6):571-9. PubMed ID: 22217270
[TBL] [Abstract][Full Text] [Related]
10. Effects of the exercise-inducible myokine irisin on proliferation and malignant properties of ovarian cancer cells through the HIF-1 α signaling pathway.
Alizadeh Zarei M; Seyed Hosseini E; Haddad Kashani H; Ahmad E; Nikzad H
Sci Rep; 2023 Jan; 13(1):170. PubMed ID: 36599894
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
[TBL] [Abstract][Full Text] [Related]
13. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
14. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
15. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
Zeng X; Morgenstern R; Nyström AM
Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
[TBL] [Abstract][Full Text] [Related]
18. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
Chovolou Y; Wätjen W; Kampkötter A; Kahl R
Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
[TBL] [Abstract][Full Text] [Related]
20. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
